Becton, Dickinson and Co. Stock Prediction
AI-powered sentiment analysis and prediction trends for BDX, updated each market day.
BDX AI Sentiment
AI sees no strong directional signal for Becton, Dickinson and Co. stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Becton, Dickinson and Co.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Sector
Exchange
Market Cap
$49,405,517,784
Cap Tier
Employees
72,000
Headquarters
FRANKLIN LAKES, NJ
Listed Since
Sept. 25, 1963
Website
BDX Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BDX Volatility
Becton, Dickinson and Co. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
